Journals / Journal of Clinical and Analytical Medicine / 2015 / Cilt: 6 - Sayı: 1

Kolon Kanserinde Helikobakter Pylori Seropozitifliği

Helicobacter Pylori Seropostivity of Colon Cancer

Pages
79–82
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies with healthy controlsmay provide detailed information about whether H.pylori seropositivity is associated with colorectal cancer etiology.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Until now many researches have showed that Helicobacter pylori infection may be etiological factor of colorectal cancer.
📊
Key Findings & Data:H.pylori Ig G level were quantitatively measured with ELISA method and levels above 5 arbU/ml were ac- cepted as seropositive.
💡
Conclusion & Impact:Further studies with healthy controlsmay provide detailed information about whether H.pylori seropositivity is associated with colorectal cancer etiology.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Until now many researches have showed that Helicobacter pylori infection may be etiological factor of colorectal cancer. The aim of currentstudy was to investigate the frequency of H.pylori infection seropositivity ofcolorectal cancer patients and compare the clinicopathological features ofH.pylori positive patients with negative ones. Material and Method: Seventyfour colorectal patients were included in study. Retrospectively, patients clinical features, surgery history and pathological characteristics were screened.Patients group serum samples were collected. H.pylori Ig G level were quantitatively measured with ELISA method and levels above 5 arbU/ml were ac- cepted as seropositive. Results: Patients median age was 60.5 ( range 26-83)and 56.8% (n=42) were male. H.pylori Ig G was positive in 37.8% (n=28) andnegative in 62.2% (n=46) of patient group. H.pylori serpositive and negative patients median age of diagnosis were 56 and 64 respectively (p=0.01).There were no significant difference between H.pylori seropositive groupwhen compared with negative group according to age, level of CEA andCa 19-9, stage, lymph node involvement, perineural and vascular invasion,presence of polyps, differantion, localisation of tumours. Discussion: H.pyloriseropositive patients were diagnosed at younger age. Association of thisfinding with etiology was confusing. Further studies with healthy controlsmay provide detailed information about whether H.pylori seropositivity is associated with colorectal cancer etiology.

Özet

Amaç: Yapılan bazı çalışmalarda Helicobacter pylori (H.pylori) enfeksiyonunun kolorektal kanser etiyolojisiyle ilişkili olabileceği belirtilmiştir. Bu çalışmada kolorektal kanserli hastalarımızda H.pylori seropozitifliği sıklığını ve bu hastaların klinikopatolojik özelliklerini negatif olanlarla karılaştırmayı amaçladık. Gereç ve Yöntem: Yetmiş dört kolorektal kanser tanısı bulunan hastamızın genel özellikleri, cerrahi ve patoloji bilgileri arşiv verilerinden retrospektif olarak tarandı. Çalışmaya dahil edilen hastalardan serum örnekleri alınarak ELI- SA yöntemi ile H.pylori Ig G düzeyi kantitatif olarak ölçüldü. 5 arbU/ml düzeyi- nin üstü seropozitif olarak kabul edildi. Bulgular: Hastaların ortanca yaşı 60.5 (aralık:26-83) idi. %56.8 (n=42) hasta erkekti. Hastaların %37.8inde (n=28) H.pylori Ig G pozitif, %62.2sinde (n=46) negatif olarak bulundu. H.pylori se- ropozitif olan hastaların ortanca tanı yaşı 56 iken negatif olanların tanı yaşı 64 idi (p=0.01). H.pylori seropozitifliği ile cinsiyet, CEA düzeyi, CA 19-9 düzeyi, evre, lenf nodu tutulumu, perinöral invazyon, vasküler invazyon, polip varlığı, diferansiasyon, tümör lokalizasyonu arasında anlamlı fark bulunamadı. Tartışma: H.pylori seropozitif hastaların daha genç yaşta tanı almışlardır. Bu bulgunun etiyoloji ile ilişkili olup olmadığı net değildir. Sağlıklı kontrollerle yapılacak çalışmalar H. pylori pozitifliğinin etiyoloji ile ilişkisi olup olmadığı konusunda detaylı veriler elde etmesini sağlayabilir.

🔖

Cite This Article

YAZICI, O., UNCU, D., AKSOY, S., SEZER, S., ZENGİN, N., AKINCI, B., YILDIZ, A., CİVELEK, B., KÖŞ, F., ÖZDEMİR, N. (2022). Kolon Kanserinde Helikobakter Pylori Seropozitifliği. Journal of Clinical and Analytical Medicine, Cilt: 6 - Sayı: 1, 79–82. https://ajindex.com/articles/561057

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325(16):1127-31
  2. Parsonnet J, Isaacson PG. Bacterial infection and MALT lymphoma. N Engl J Med 2004;350(3):213-5
  3. Konturek PC, Hartwich A, Zuchowicz M, Labza H, Pierzchalski P, Karczewska E, et al. Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer. J Physiol Pharmacol 2000;51(4 Pt 1):737-49
  4. Konturek SJ, Konturek PC, Hartwich A, Hahn EG. Helicobacter pylori infection and gastrin and cyclooxygenase expression in gastric and colorectal malignancies. Regul Pept 2000;93(1-3):13-9
  5. Smith AM, Watson SA. Review article: gastrin and colorectal cancer. Aliment Pharmacol Ther 2000;14(10):1231-47
  6. Ciccotosto GD, McLeish A, Hardy KJ, Shulkes A. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995;109(4):1142-53
  7. Cummings LC, Cooper GS. Colorectal cancer screening: update for 2011. Semin Oncol 2011;38(4):483-9
  8. Gustin DM, Brenner DE. Chemoprevention of colon cancer: current status and future prospects. Cancer Metastasis Rev 2002;21(3-4):323-48
  9. Williams MP, Pounder RE. Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol. 1999;94(11):11-6
  10. Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, et al. Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion 1999;60(3):210-5
  11. Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A. Helicobacter pylori: seroprevalence and colorectal cancer. Isr Med Assoc J 2000;2(1):6-9
  12. Mizuno S, Morita Y, Inui T, Asakawa A, Ueno N, Ando T, et al. Helicobacter pylori infection is associated with colon adenomatous polyps detected by high- resolution colonoscopy. Int J Cancer 2005;117(6):1058-9
  13. Fujimori S, Kishida T, Kobayashi T, Sekita Y, Seo T, Nagata K, et al. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol 2005;40(9):887-93
  14. Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA. Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst 1995;87(10):762-3
  15. Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, et al. High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastro